REGORAFENIB

Clinical trials for REGORAFENIB explained in plain language.

Never miss a new study

Get alerted when new REGORAFENIB trials appear

Sign up with your email to follow new studies for REGORAFENIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Three-Pronged attack on Tough-to-Treat colon cancer

Disease control Recruiting now

This early-stage study is testing a new three-part treatment for advanced colorectal cancer that has stopped responding to standard therapies. It combines an immunotherapy drug, a targeted cancer drug, and a personalized cell therapy made from the patient's own immune cells. The …

Matched conditions: REGORAFENIB

Phase: EARLY_PHASE1 • Sponsor: JIANG LONGWEI • Aim: Disease control

Last updated Mar 09, 2026 14:26 UTC

REGORAFENIB

Get alerted when new REGORAFENIB trials appear

Three-Pronged attack on Tough-to-Treat colon cancer